Anti-CD38 therapy in kidney allograft antibody-mediated rejection and microvascular inflammation: a systematic review and evidence map

Chengze Liang, Chunmei Wang, Saifu Yin, Turun Song, Tao Lin

Open source

DOI
10.1016/j.trre.2026.101065
Published
2026-12
Container
Transplantation Reviews
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trre.2026.101065,
  title = {Anti-CD38 therapy in kidney allograft antibody-mediated rejection and microvascular inflammation: a systematic review and evidence map},
  author = {Chengze Liang and Chunmei Wang and Saifu Yin and Turun Song and Tao Lin},
  year = {2026},
  journal = {Transplantation Reviews},
  doi = {10.1016/j.trre.2026.101065},
  url = {https://doi.org/10.1016/j.trre.2026.101065}
}

RIS

TY  - JOUR
TI  - Anti-CD38 therapy in kidney allograft antibody-mediated rejection and microvascular inflammation: a systematic review and evidence map
AU  - Chengze Liang
AU  - Chunmei Wang
AU  - Saifu Yin
AU  - Turun Song
AU  - Tao Lin
PY  - 2026
JO  - Transplantation Reviews
DO  - 10.1016/j.trre.2026.101065
UR  - https://doi.org/10.1016/j.trre.2026.101065
ER  - 

APA

Liang, C., Wang, C., Yin, S., Song, T., & Lin, T. (2026). Anti-CD38 therapy in kidney allograft antibody-mediated rejection and microvascular inflammation: a systematic review and evidence map. Transplantation Reviews. https://doi.org/10.1016/j.trre.2026.101065

Source records